reputation

Trump pictured March 26 2020
Marketing

Pharma's reputation is stable-ish. Will that survive Trump 2.0?

After the whiplash changes of the COVID-19 era, pharma’s reputation has stabilized in recent years. Enter Donald Trump.
Nick Paul Taylor Dec 19, 2024 5:00am
Brain and money connected by a thread on a white background

Neurology patients call out pharma for inadequate investment

Nov 19, 2024 11:20am
Gilead

Gilead leads Asian patient groups' drugmaker reputation rankings

Sep 25, 2024 10:40am
A compass pointing at brand on the dial

Corporate reputation influences drug prescribing choices: survey

Sep 10, 2024 9:00am
target reach ladder climb meet win beat competition

Roche regains reputation crown among rare disease patient groups

Aug 20, 2024 11:25am
Obesity drugs

Lilly, Novo rank 3rd, 4th on list of pharmas linked to obesity

Jul 2, 2024 7:35am